+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis



Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis



Annals of Neurology 25(1): 98-102



We studied the incidence and clinical correlates of serum antibodies to GM1 and GD1a gangliosides in patients with classical amyotrophic lateral sclerosis (ALS) and other "motor nerve" syndromes. Serum antibodies to GM1 and GD1a gangliosides were measured using enzyme-linked immunosorbent assays. Our results showed that polyclonal immunoglobulin M (IgM) antibodies to the GM1 or GD1a ganglioside or both were present at serum dilutions of 1:25 to 1:4,000 in 78% (57/73) of patients with ALS. Only 8% of normal controls had similar antibodies. The pattern of serum antibody reactivity correlated with the pattern of clinical involvement in our patients. Selective reactivity to GD1a ganglioside was common when upper motor neuron signs were prominent. IgM reactivity to GM1 ganglioside was common in ALS patients with prominent lower motor neuron signs. Most patients with motor neuropathies had serum reactivity to both GM1 and GD1a gangliosides. These results provide further evidence of ongoing autoimmune processes in ALS patients. There is a strong relationship between serum antiganglioside antibodies and patterns of clinical involvement in ALS.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007636916

Download citation: RISBibTeXText

PMID: 2913936

DOI: 10.1002/ana.410250118


Related references

Amyotrophic lateral sclerosis associated with IgG anti-GalNAc-GD1a antibodies. Clinical Neurology and Neurosurgery 110(7): 722-724, 2008

Serum antibodies to cytoplasmic antigens of the human brain in patients with disseminated sclerosis and amyotrophic lateral sclerosis. Zhurnal Nevropatologii i Psikhiatrii Imeni S S Korsakova 77(2): 198-201, 1977

Serum antibodies to cytoplasmic antigens of the human brain in patients with multiple sclerosis and amyotrophic lateral sclerosis. Soviet Neurology and Psychiatry: 3-8,, 1978

Serum IgG antibodies to GD1a and GM1 gangliosides in elderly people. Biomeditsinskaia Khimiia 62(1): 93-95, 2016

Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology 38(9): 1457-1461, 1988

Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis. Journal of Neuroimmunology 225(1-2): 149-152, 2010

Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis. JAMA Neurology 72(6): 676-681, 2015

LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients. Annals of Clinical and Translational Neurology 1(2): 80-87, 2014

Serum anti-neuronal antibodies in amyotrophic lateral sclerosis. International Journal of Neuroscience 123(8): 557-562, 2013

Antineural antibodies in the serum of patients with amyotrophic lateral sclerosis. Neurology 37(1): 152-155, 1987

Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2. Internal Medicine 42(3): 277-280, 2003

Antibodies against fetal muscle proteins in serum from patients with amyotrophic lateral sclerosis. Neurology 39(5): 683-686, 1989

Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis. European Journal of Neurology 17(4): 562-566, 2010

Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. New England Journal of Medicine 327(24): 1721-1728, 1992

Anti-annexin V antibodies in the cerebrospinal fluid and serum of patients with amyotrophic lateral sclerosis. Neurological Sciences 24(4): 273-274, 2003